Abstract

The FAD-dependent glucose dehydrogenase from Burkholderia cepacia (FADGDH) is a hetero-oligomeric enzyme that is capable of direct electron transfer (DET) with an electrode. The cytochrome c (cyt c) subunit, which possesses three hemes (heme 1, heme 2, and heme 3, from the N-terminal sequence), is known to enable DET; however, details of the electron transfer pathway remain unknown. A mutagenesis investigation of the heme axial ligands was carried out to elucidate the electron transfer pathway to the electron mediators and/or the electrode. The sixth axial ligand for each of the three heme irons, Met109, Met263, and Met386 were substituted with His. The catalytic activities of the wild-type (WT) and mutant enzymes were compared by investigating their dye-mediated dehydrogenase activities and their DET abilities toward the electrode. The results suggested that (1) heme 1 with Met109 as an axial ligand is mainly responsible for the electron transfer with electron acceptors in the solution, but not for the DET with the electrode; (2) heme 2 with Met263 is responsible for the DET-type reaction with the electrode; and (3) heme 3 with Met386 seemed to be the electron acceptor from the catalytic subunit. From these results, two electron transfer pathways were proposed depending on the electron acceptors. Electrons are transferred from the catalytic subunit to heme 3, then to heme 2, to heme 1 and, finally, to electron acceptors in solution. However, if the enzyme complex is immobilized on the electrode and is used as electron acceptors, electrons are passed to the electrode from heme 2.

Highlights

  • The monitoring of blood glucose is essential for diabetes therapy

  • More attention has been given to continuous glucose monitoring (CGM), in which the glucose concentration of interstitial fluid is measured continuously by a glucose sensor inserted subcutaneously or by non-invasive methods [1]

  • With the catalytic subunit alone, the dehydrogenase activities using 2-hexaamineruthenium(III) chloride was almost negligible compared with those using Phenazine methosulfate (PMS)-DCPIP

Read more

Summary

Introduction

The monitoring of blood glucose is essential for diabetes therapy. More attention has been given to continuous glucose monitoring (CGM), in which the glucose concentration of interstitial fluid is measured continuously by a glucose sensor inserted subcutaneously or by non-invasive methods [1]. CGM together with the combination of sensor augmented insulin infusion technologies is currently the most advanced biomedical engineering in diabetes therapy. The U.S Food and Drug Administration approved the first automated insulin delivery device for type 1 diabetes [2]. Conventional enzyme sensors require electron mediators to transfer electrons to the electrode. DET-type enzyme sensors transfer electrons directly from the enzyme to the electrode.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call